|The economic burden of skeletal-related events among elderly men with metastatic prostate cancer|
J Jayasekera, E Onukwugha, K Bikov, CD Mullins, B Seal, A Hussain
Pharmacoeconomics 32 (2), 173-191, 2014
|Irrational fixed dose combinations in Nepal: need for intervention|
A Poudel, S Palaian, PR Shankar, J Jayasekera, MIM Izham
Kathmandu University Medical Journal 6 (3), 399-405, 2008
|ReCAP: impact of multidisciplinary care on processes of cancer care: a multi-institutional study|
E Onukwugha, NJ Petrelli, KM Castro, JF Gardner, J Jayasekera, ...
Journal of oncology practice 12 (2), 155-156, 2016
|Cost effectiveness of gene expression profile testing in community practice|
Y Chandler, CB Schechter, J Jayasekera, A Near, SC O’Neill, C Isaacs, ...
Journal of Clinical Oncology 36 (6), 554, 2018
|Effects of radiotherapy in early-stage, low-recurrence risk, hormone-sensitive breast cancer|
J Jayasekera, CB Schechter, JA Sparano, R Jagsi, J White, ...
JNCI: Journal of the National Cancer Institute 110 (12), 1370-1379, 2018
|Potential impact of cessation interventions at the point of lung cancer screening on lung cancer and overall mortality in the United States|
P Cao, J Jeon, DT Levy, JC Jayasekera, CJ Cadham, JS Mandelblatt, ...
Journal of Thoracic Oncology 15 (7), 1160-1169, 2020
|Structure, function, and applications of the Georgetown–Einstein (GE) breast cancer simulation model|
CB Schechter, AM Near, J Jayasekera, Y Chandler, JS Mandelblatt
Medical Decision Making 38 (1_suppl), 66S-77S, 2018
|Expected monetary impact of oncotype DX score-concordant systemic breast cancer therapy based on the TAILORx trial|
A Mariotto, J Jayasekerea, V Petkov, CB Schechter, L Enewold, ...
JNCI: Journal of the National Cancer Institute 112 (2), 154-160, 2020
|Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis|
CJ Cadham, JC Jayasekera, SM Advani, SJ Fallon, JL Stephens, ...
Lung Cancer 135, 205-216, 2019
|Racial disparities in urologist visits among elderly men with prostate cancer: A cohort analysis of patient‐related and county of residence‐related factors|
E Onukwugha, P Osteen, J Jayasekera, CD Mullins, CA Mair, A Hussain
Cancer 120 (21), 3385-3392, 2014
|Simulation modeling of cancer clinical trials: application to omitting radiotherapy in low-risk breast cancer|
J Jayasekera, Y Li, CB Schechter, R Jagsi, J Song, J White, G Luta, ...
JNCI: Journal of the National Cancer Institute 110 (12), 1360-1369, 2018
|Simulation of chemotherapy effects in older breast cancer patients with high recurrence scores|
Y Chandler, JC Jayasekera, CB Schechter, C Isaacs, CJ Cadham, ...
JNCI: Journal of the National Cancer Institute 112 (6), 574-581, 2020
|Study protocol for a telephone-based smoking cessation randomized controlled trial in the lung cancer screening setting: The lung screening, tobacco, and health trial|
KL Taylor, DE Deros, S Fallon, J Stephens, E Kim, T Lobo, KM Davis, ...
Contemporary clinical trials 82, 25-35, 2019
|Systematic review of the cost effectiveness of breast cancer prevention, screening, and treatment interventions|
J Jayasekera, JS Mandelblatt
Journal of Clinical Oncology 38 (4), 332, 2020
|Question Prompt List to Support Patient-Provider Communication in the Use of the 21-Gene Recurrence Test: Feasibility, Acceptability, and Outcomes|
J Jayasekera, ST Vadaparampil, S Eggly, RL Street Jr, T Foster Moore, ...
JCO Oncology Practice 16 (10), e1085-e1097, 2020
|The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations|
L Panattoni, TA Lieu, J Jayasekera, S O’Neill, JS Mandelblatt, R Etzioni, ...
Breast cancer research and treatment 173 (2), 417-427, 2019
|Cost prediction using a survival grouping algorithm: An application to incident prostate cancer cases|
E Onukwugha, R Qi, J Jayasekera, S Zhou
PharmacoEconomics 34 (2), 207-216, 2016
|Prevalence of fixed dose drug combinations in nepal: a preliminary study|
A Poudel, S Palaian, P Mishra, IM Mohamed, J Jayasekera
J Clin Diagn Res 4, 2246-52, 2010
|Contextual analysis of the effect of prostate-specific antigen testing on prostate cancer outcomes among elderly men|
J Jayasekera, E Onukwugha, S Tom, D Harrington, FG Pradel, M Naslund
Value in Health 19 (3), A98, 2016
|Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study|
CJ Cadham, P Cao, J Jayasekera, KL Taylor, DT Levy, J Jeon, EB Elkin, ...
JNCI: Journal of the National Cancer Institute, 2021